Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease
Expert one on one coaching to keep you on track for lasting success
Healthcare providers can tailor a treatment plan that considers individual factors, including medical history, concurrent medications, and lifestyle
National Research Council (U.S.)
It increases the risk of: Type 2 diabetes MASLD (metabolic dysfunction-associated steatotic liver disease, formerly called NAFLD) Cardiovascular disease The loss of estrogen also accelerates sarcopenia, the loss of lean muscle mass, which further slows metabolism and reduces energy expenditure
/assets/images/provider/photos/2826746.png)
US$ 21.30
US$ 25.54
US$ 22.77
